Literature DB >> 1313208

Time-weighted averages, peaks, and other indices of exposure in occupational epidemiology.

H Checkoway1, C H Rice.   

Abstract

Dose surrogates commonly used in occupational epidemiology are exposure intensity, exposure duration, and cumulative exposure. The appropriateness of any of these measures as dose indicators depends on the nature of the induction process for the disease under consideration. Peak exposure intensity is often associated with acute health outcomes, whereas cumulative exposure is generally more relevant for diseases with long induction times, i.e., "chronic" diseases. However, there may be situations where peak exposure is etiologically relevant in chronic disease induction, such as might occur with nonlinear rates of damage during brief intervals of very high exposure. An approach is described for evaluating the effect of peak exposures in which peaks may be defined on a relative basis for each worker, or with respect to an absolute value, such as the permissible occupational exposure limit. The analytic strategy is illustrated with data from a case-control study of silicosis in relation to quantitative estimates of silica exposure. In this example, relative peak exposures and average non-peak exposures appear to be better predictors of silicosis risk than cumulative exposure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313208     DOI: 10.1002/ajim.4700210106

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  11 in total

1.  Rethinking cumulative exposure in epidemiology, again.

Authors:  Frank de Vocht; Igor Burstyn; Nuthchyawach Sanguanchaiyakrit
Journal:  J Expo Sci Environ Epidemiol       Date:  2014-08-20       Impact factor: 5.563

2.  Investigating time patterns of variation in radiation cancer associations.

Authors:  D B Richardson; J P Ashmore
Journal:  Occup Environ Med       Date:  2005-08       Impact factor: 4.402

3.  Silica dust and lung cancer in the German stone, quarrying, and ceramics industries: results of a case-control study.

Authors:  K Ulm; B Waschulzik; H Ehnes; K Guldner; B Thomasson; A Schwebig; H Nuss
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

4.  Risk of end-stage renal disease among liver transplant recipients with pretransplant renal dysfunction.

Authors:  R Ruebner; D Goldberg; P L Abt; R Bahirwani; M Levine; D Sawinski; R D Bloom; P P Reese
Journal:  Am J Transplant       Date:  2012-07-03       Impact factor: 8.086

5.  Time-varying associations between an exposure history and a subsequent health outcome: a landmark approach to identify critical windows.

Authors:  Cécilia Samieri; Cécile Proust-Lima; Maude Wagner; Francine Grodstein; Karen Leffondre
Journal:  BMC Med Res Methodol       Date:  2021-11-27       Impact factor: 4.615

6.  Use of a crop and job specific exposure matrix for retrospective assessment of long-term exposure in studies of chronic neurotoxic effects of agrichemicals.

Authors:  L London; J E Myers
Journal:  Occup Environ Med       Date:  1998-03       Impact factor: 4.402

Review 7.  Occupational asthma risk from exposures to toluene diisocyanate: A review and risk assessment.

Authors:  Robert D Daniels
Journal:  Am J Ind Med       Date:  2018-02-01       Impact factor: 2.214

8.  Silica, silicosis and lung-cancer: results from a cohort study in the stone and quarry industry.

Authors:  K Ulm; P Gerein; J Eigenthaler; S Schmidt; H Ehnes
Journal:  Int Arch Occup Environ Health       Date:  2004-05-20       Impact factor: 3.015

Review 9.  Peak Inhalation Exposure Metrics Used in Occupational Epidemiologic and Exposure Studies.

Authors:  M Abbas Virji; Laura Kurth
Journal:  Front Public Health       Date:  2021-01-08

Review 10.  Radiofrequency Electromagnetic Radiation and Memory Performance: Sources of Uncertainty in Epidemiological Cohort Studies.

Authors:  Christopher Brzozek; Kurt K Benke; Berihun M Zeleke; Michael J Abramson; Geza Benke
Journal:  Int J Environ Res Public Health       Date:  2018-03-26       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.